• Makeen Baroudi, Anna Rezk, Mohammad Daher, Mariah Balmaceno-Criss, Jerzy George Gregoryczyk, Yatharth Sharma, Christopher L McDonald, Bassel G Diebo, and Alan H Daniels.
• Department of Orthopedic Surgery, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
• Injury. 2024 Jun 1; 55 (6): 111472111472.

AbstractSpinal Cord Injury (SCI) is a condition leading to inflammation, edema, and dysfunction of the spinal cord, most commonly due to trauma, tumor, infection, or vascular disturbance. Symptoms include sensory and motor loss starting at the level of injury; the extent of damage depends on injury severity as detailed in the ASIA score. In the acute setting, maintaining mean arterial pressure (MAP) higher than 85 mmHg for up to 7 days following injury is preferred; although caution must be exercised when using vasopressors such as phenylephrine due to serious side effects such as pulmonary edema and death. Decompression surgery (DS) may theoretically relieve edema and reduce intraspinal pressure, although timing of surgery remains a matter of debate. Methylprednisolone (MP) is currently used due to its ability to reduce inflammation but more recent studies question its clinical benefits, especially with inconsistency in recommending it nationally and internationally. The choice of MP is further complicated by conflicting evidence for optimal timing to initiate treatment, and by the reported observation that higher doses are correlated with increased risk of complications. Thyrotropin-releasing hormone may be beneficial in less severe injuries. Finally, this review discusses many options currently being researched and have shown promising pre-clinical results.Copyright © 2024 Elsevier Ltd. All rights reserved.

24 keywords...

hide…